Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY ☆
Titel:
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY ☆
Auteur:
Kataoka, K. Mori, K. Nakamura, Y. Watanabe, J. Akazawa, N. Hirata, K. Yokota, M. Kato, K. Kotaka, M. Yamazaki, K. Kagawa, Y. Mishima, S. Ando, K. Miyo, M. Yukami, H. Laliotis, G. Sharma, S. Palsuledesai, C.C. Rabinowitz, M. Jurdi, A. Liu, M.C. Aleshin, A. Kotani, D. Bando, H. Taniguchi, H. Takemasa, I. Kato, T. Yoshino, T. Oki, E.